This issue includes all the latest pharma news, from AstraZeneca’s $1.5bn investment into a new antibody drug conjugate facility in Singapore (
page 4) and GSK sharing positive results from its phase 3 trials for a new asthma treatment (
page 6), to the US Food and Drug Administration’s approval of Roche’s self-collection screening option for HPV (
page 8) and Biogen’s acquisition of Human Immunology Biosciences for $1.15bn (
page 12).